Modern principles of atrial fibrillation therapy in patients with chronic heart failure

Modern principles of atrial fibrillation therapy in patients with chronic heart failure

The review is devoted to an actual problem of modern cardiology – atrial fibrillation (AF) treatment in patients with chronic heart failure (CHF). Multicenter clinical trials demonstrated that CHF patients have AF more often than individuals without CHF. Algorhythms for choosing optimal antiarrhythm...

Full description

Bibliographic Details
Main Authors:	A. I. Tarzimanova, I. G. Fomina, A. V. Vetluzhsky, M. V. Syrtsova
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2005-06-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	фибрилляция предсердий хроническая сердечная недостаточность терапия антиаритмические препараты
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/957

Similar Items

Bisoprolol and sotalol for maintaining sinus rhythm in patients with paroxysmal atrial fibrillation and chronic heart failure
by: S. N. Tereshchenko, et al.
Published: (2005-12-01)

Prevention of atrial fibrillation episodes in patients with chronic heart failure: a new approach to the old problem
by: Yu. M. Pozdnyakov, et al.
Published: (1970-01-01)

Dronedarone — an antiarrythmic agent with new potential for atrial fibrillation treatment
by: M. Yu. Gilyarov, et al.
Published: (2010-12-01)

CARDIOSTIMULATION AND RHYTHM DISORDERS IN PATIENTS WITH CHRONIC HEART FAILURE
by: S. I. Stupakov
Published: (2015-06-01)

CARDIAC INSUFFICIENCY FREQUENCY AND ANTI-THROMBOTIC THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION ACCORDING TO THE INFORMATION PROVIDED BY THE HOSPITAL REGISTR KRAF
by: Nikolai Gamletovich Gogolashvili, et al.
Published: (2019-07-01)

Antiarrhythmic therapy choice in patients with left ventricular diastolic dysfunction and atrial fibrillation
by: A. V. Tarasov, et al.
Published: (1970-01-01)

The first Russian register of patients with chronic heart failure and atrial fibrillation (RIF-CHF): study design
by: S. N. Tereshchenko, et al.
Published: (2015-12-01)

ASSOCIATION OF RS2200733 POLYMORPHISM WITH ANTIARRHYTHMIC THERAPY AND PROGRESSION OF ATRIAL FIBRILLATION IN THE UZBEK POPULATIO
by: R. D. Kurbanov, et al.
Published: (2020-12-01)

ENDOTHELIAL ADHESIVE FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE COMPLICATED BY CHRONIC HEART FAILURE AND ATRIAL FIBRILLATION
by: A. N. Zakirova, et al.
Published: (2015-09-01)

Reverse remodeling against the background of cardiac contractility modulation therapy in patients with heart failure and atrial fibrillation
by: A. A. Safiullina, et al.
Published: (2022-02-01)

Antiarrhythmic therapy in the treatment of atrial fibrillation: yesterday, today, tomorrow
by: V. I. Podzolkov, et al.
Published: (2019-06-01)

2013 ESC GUIDELINES ON CARDIAC PACING AND CARDIAC RESYNCHRONIZATION THERAPY
by: Michele Brignole, et al.
Published: (2014-04-01)

Atorvastain effectiveness in patients with heart failure, preserved systolic function, and paroxysmal atrial fibrillation
by: E. S. Kozlova, et al.
Published: (2009-12-01)

Antiarrhythmic therapy for atrial fibrillation: current guidelines of the European Society of Cardiology and the European Association for Cardio-Thoracic Surgery (ESC/EACTS)
by: A. I. Tarzimanova, et al.
Published: (2021-09-01)

Frequency of arrythmia depending on the severity of the functional class in patients with metabolic syndrome and heart failure
by: D. K. Kurbanova, et al.
Published: (2022-03-01)

Pathogenesis of chronic heart failure: change of dominating paradigm
by: V. V. Kalyuzhin, et al.
Published: (2007-12-01)

Inotropic myocardial function dynamics in patients with recurrent atrial fibrillation
by: N. E. Gaidamakina, et al.
Published: (2006-06-01)

A SELECTIVE ANTAGONIST OF MINERALOCORTICOID RECEPTOR EPLERENONE IN CARDIOLOGY PRACTICE
by: B. B. Gegenava, et al.
Published: (2015-09-01)

Propafenone effect on inotropic myocardial function in patients with recurrent atral fibrillation
by: I. G. Fomina, et al.
Published: (2006-06-01)

ATRIAL FIBRILLATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: E. I. Leonova, et al.
Published: (2015-09-01)

HEART RATE-LOWERING THERAPY IN THE TREATMENT OF CHRONIC HEART FAILURE
by: S. V. Shalaev, et al.
Published: (2015-09-01)

ROLE OF THE METABOLITE THERAPY FOR THE TREATMENT OF CHRONIC HEART FAILURE
by: L. N. Maksimova, et al.
Published: (2015-09-01)

CHRONIC KIDNEY DISEASE AND CARDIOVASCULAR DISEASES: FOCUS ON ATRIAL FIBRILLATION
by: V. N. Shishkova
Published: (2015-09-01)

ПРОГНОСТИЧЕСКОЕ ЗНАЧЕНИЕ СУБСТРАТОВ СИСТЕМЫ НАТРИЙУРЕТИЧЕСКИХ ПЕПТИДОВ В ОЦЕНКЕ РИСКА РАЗВИТИЯ ЖЕЛУДОЧКОВЫХ АРИТМИЙ У ПАЦИЕНТОВ С СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ И ФИБРИЛЛЯЦИЕЙ ПРЕДСЕРДИЙ
by: M. Ch. Matsiukevich, et al.
Published: (2022-07-01)

Analysis of antithrombotic therapy of atrial fibrillation in international and Russian registries
by: O. V. Reshetko, et al.
Published: (2019-08-01)

CHANGES IN THE LEVEL OF NATRIURETIC PEPTIDES IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMIC DRUGS
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

Evaluation of adherence of patients with atrial fibrillation to anticoagulant therapy at the outpatient stage of treatment
by: A. V. Sokolov, et al.
Published: (2021-12-01)

RIVAROXABAN IN THE PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ATRIAL FIBRILLATION
by: M. Yu. Gilyarov
Published: (2015-12-01)

Fluid retention in patients with paroxysmal and permanent atrial fibrillation and heart failure
by: V. V. Kirillova, et al.
Published: (2020-11-01)

CURRENT PRINCIPLES AND TRENDS OF ATRIAL FIBRILLATION PHARMACOTHERAPY
by: Yu. A. Bunin
Published: (2016-01-01)

Atrial Fibrillation and Heart Failure as the Onset of AL-Amyloidosis
by: E. V. Reznik, et al.
Published: (2021-11-01)

THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY
by: M. Yu. Gilyarov
Published: (2015-12-01)

ПРОБЛЕМА ОТСУТСТВИЯ ОТВЕТА НА КАРДИОРЕСИНХРОНИЗАЦИОННУЮ ТЕРАПИЮ ПРИ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ
by: S. I. Stupakov
Published: (2015-10-01)

Adherence to therapy, lifestyle modification and medical support of cardiovascular patients
by: S. S. Bunova, et al.
Published: (2020-12-01)

STROKE AS A RISK FACTOR IN PATIENTS WITH ATRIAL FIBRILLATION ACCORDING TO THE KRAF HOSPITAL REGISTER
by: Alexander Aleksandrovich Tuchkov, et al.
Published: (2019-07-01)

ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS
by: M. Yu. Gilyarov, et al.
Published: (2016-01-01)

Autonomous nervous system and cardiac arrhythmias in patients with recurrent atrial fibrillation: long-term electrocardiogram monitoring data
by: A. V. Vetluzhsky, et al.
Published: (2007-08-01)

СВЯЗЬ ПОЛИМОРФНОГО ВАРИАНТА RS989692 ГЕНА НЕПРИЛИЗИНА (MME) С УРОВНЕМ НАТРИЙУРЕТИЧЕСКИХ ПЕПТИДОВ И ЕГО КЛИНИЧЕСКОЕ ЗНАЧЕНИЕ У ПАЦИЕНТОВ С СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТЬЮ И ФИБРИЛЛЯЦИЕЙ ПРЕДСЕРДИЙ
by: М. Ч. Матюкевич, et al.
Published: (2023-05-01)

Prognostic value of high-resolution electrocardiography parameters, heart rate variability, and QT interval dynamics in patients with chronic heart failure
by: A. E. Radzevich, et al.
Published: (2006-08-01)

Propafenone in restoring sinus rhythm among patients with persistent atrial fibrillation. PROMETEY – an open, multicenter, pilot study performed in the Russian Federation (part II)
by: I. G. Fomina, et al.
Published: (2005-10-01)